PharmaCyte Biotech, Inc. 13D and 13G filings for MyMD Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-30 4:05 pm Purchase | 2024-05-23 | 13D | MyMD Pharmaceuticals, Inc. MYMD | PharmaCyte Biotech Inc. PMCB | 11,563,878 83.400% | 11,563,878 (New Position) | Filing |